Virtu Financial’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-133,886
Closed -$363K 1868
2025
Q4
$363K Buy
133,886
+120,542
+903% +$396K 0.01% 757
2025
Q3
$56K Buy
+13,344
New +$58.7K ﹤0.01% 1117
2025
Q2
Sell
-34,924
Closed -$154K 1670
2025
Q1
$154K Buy
34,924
+11,918
+52% +$55.9K 0.01% 867
2024
Q4
$107K Buy
+23,006
New +$126K 0.01% 1010
2023
Q3
Sell
-22,803
Closed -$126K 1508
2023
Q2
$126K Buy
+22,803
New +$123K 0.01% 959
2023
Q1
Sell
-86,169
Closed -$402K 1711
2022
Q4
$402K Buy
86,169
+70,858
+463% +$349K 0.05% 360
2022
Q3
$72K Buy
+15,311
New +$96.5K 0.01% 1141
2022
Q1
Sell
-67,707
Closed -$2.21M 1677
2021
Q4
$2.21M Buy
67,707
+35,270
+109% +$1.42M 0.23% 94
2021
Q3
$1.33M Buy
+32,437
New +$1.18M 0.12% 160
2021
Q1
Sell
-57,174
Closed -$2.31M 1760
2020
Q4
$2.31M Buy
+57,174
New +$2.63M 0.25% 84

Other funds holding GDRX

Virtu Financial's GDRX Position: Q1 2026 in Review

Virtu Financial sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 133,886 shares — an estimated $363K sold.

Virtu Financial first reported a position in GDRX in Q4 2020 and held it in 10 quarters. The position peaked at $2.31M in Q4 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Virtu Financial reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 133,886 GoodRx Holdings shares in Q1 2026, an estimated $363K.
  • Virtu Financial first reported a position in GoodRx Holdings in Q4 2020 and held it in 10 quarters.
  • Virtu Financial's GoodRx Holdings position peaked at $2.31M in Q4 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.